Cytomegalovirus glycoprotein vaccine - Antigenics
Latest Information Update: 30 Aug 1996
At a glance
- Originator Antigenics
- Class Cytomegalovirus vaccines; Glycopeptides
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cytomegalovirus infections
Most Recent Events
- 30 Aug 1996 Discontinued-Preclinical for Cytomegalovirus infections in USA (Unknown route)
- 30 Aug 1996 New profile